Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics.Published in:Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01244-4By:Tierling, Sascha;Jürgens-Wemheuer, Wiebke M.;Leismann, Alea;Becker-Kettern, Julia;Scherer, Michael;Wrede, Arne;Breuskin, David;Urbschat, Steffi;Sippl, Christoph;Oertel, Joachim;Schulz-Schaeffer, Walter J.;Walter, JörnPublication type:Article